Evidence brief Factors that optimize therapy with repetitive transcranial magnetic stimulation for treatment-resistant depression

Evidence brief Factors that optimize therapy with repetitive transcranial magnetic stimulation for treatment-resistant depression

Major depressive disorder is one of the most common mental disorders in the general and Veteran populations. The one to two-thirds of MDD patients who do not respond to the first antidepressant prescribed, and the 15% to 33% who do not respond to multiple drugs are defined as having treatment-resist...

Descripción completa

Detalles Bibliográficos
Otros Autores: Peterson, Kim, author (author), McCleery, Ellen, author, Waldrip, Kallie, author
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, DC : Department of Veterans Affairs, Health Services Research And Development Service 2014.
Colección:Evidence-based synthesis program (Series)
Materias:
Outcome assessment (Medical care)
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820278106719
Descripción
Sumario:Major depressive disorder is one of the most common mental disorders in the general and Veteran populations. The one to two-thirds of MDD patients who do not respond to the first antidepressant prescribed, and the 15% to 33% who do not respond to multiple drugs are defined as having treatment-resistant depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) is one of many possible options for treating TRD. It is supported by two FDA-cleared protocols and acceptable acute efficacy based on a recent Comparative Effectiveness Review conducted by the RTI-UNC EPC. This Evidence Brief synthesizes the literature on factors that optimize rTMS therapy in patients with TRD.
Descripción Física:1 online resource (ii, 31 pages) : illustrations
Bibliografía:Includes bibliographical references.

Ejemplares similares